Literature DB >> 16598737

Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.

Anat Bar-Shira1, Noa Matarasso, Serena Rosner, Dani Bercovich, Haim Matzkin, Avi Orr-Urtreger.   

Abstract

BACKGROUND: MSR1, PTEN, and KLF6 have been implicated as candidate susceptibility genes for prostate tumorigenesis.
METHODS: Three hundred Jewish prostate cancer patients were screened for alterations in these genes.
RESULTS: MSR1 was conserved in all patients. PTEN screening revealed a novel missense mutation and a silent change. Five KLF6 alterations were detected in 17 patients, including Q160X, the only nonsense KLF6 germline mutation described to date in a cancer patient. The KLF6 IVS1-27G>A polymorphism, recently associated with prostate cancer risk, was detected in 11.9% of the patients and 17.3% of the controls (P = 0.043). IVS1-27A allele frequency was significantly lower in prostate cancer patients (P = 0.030), specifically in Ashkenazi patients (P = 0.047) compared to controls.
CONCLUSIONS: We found no evidence that MSR1 and PTEN germline mutations are associated with prostate cancer risk in Jews. The negative association between KLF6 IVS1-27A and prostate cancer risk supports a population-specific effect of susceptibility alleles in prostate tumorigenesis. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598737     DOI: 10.1002/pros.20425

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.

Authors:  Chunmei C Xie; Lingyi Lu; Jielin Sun; S Lilly Zheng; William B Isaacs; Henrik Gronberg; Jianfeng Xu
Journal:  J Hum Genet       Date:  2011-06-02       Impact factor: 3.172

2.  Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Authors:  Ziv Gan-Or; Anat Bar-Shira; Tanya Gurevich; Nir Giladi; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2011-08-12       Impact factor: 2.660

Review 3.  Prostate cancer susceptibility loci: finding the genes.

Authors:  Elanie A Ostrander; Bo Johannesson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Fine mapping analysis confirms and strengthens linkage of four chromosomal regions in familial hypospadias.

Authors:  Cilla Söderhäll; Izabella Baranowska Körberg; Hanh T T Thai; Jia Cao; Yougen Chen; Xufeng Zhang; Zu Shulu; Loes F M van der Zanden; Iris A L M van Rooij; Louise Frisén; Nel Roeleveld; Ellen Markljung; Ingrid Kockum; Agneta Nordenskjöld
Journal:  Eur J Hum Genet       Date:  2014-07-02       Impact factor: 4.246

5.  KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.

Authors:  XiaoMei Liu; Alejandro Gomez-Pinillos; Charisse Loder; Enrique Carrillo-de Santa Pau; Ruifang Qiao; Pamela D Unger; Ralf Kurek; Carole Oddoux; Jonathan Melamed; Robert E Gallagher; John Mandeli; Anna C Ferrari
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

6.  Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.

Authors:  Christophe Bureau; Naima Hanoun; Jérôme Torrisani; Jean-Pierre Vinel; Louis Buscail; Pierre Cordelier
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

7.  Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.

Authors:  Lizhong Wang; Runhua Liu; Weiquan Li; Chong Chen; Hiroto Katoh; Guo-Yun Chen; Beth McNally; Lin Lin; Penghui Zhou; Tao Zuo; Kathleen A Cooney; Yang Liu; Pan Zheng
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

8.  Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.

Authors:  Kangdong Liu; Chanmi Park; Hanyong Chen; Joonsung Hwang; N R Thimmegowda; Eun Young Bae; Ki Won Lee; Hong-Gyum Kim; Haidan Liu; Nak Kyun Soung; Cong Peng; Jae Hyuk Jang; Kyoon Eon Kim; Jong Seog Ahn; Ann M Bode; Ziming Dong; Bo Yeon Kim; Zigang Dong
Journal:  Mol Carcinog       Date:  2014-04-04       Impact factor: 4.784

9.  Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.

Authors:  Qiang Wang; Ruixian Peng; Boshi Wang; Jifeng Wang; Wandong Yu; Yongzhong Liu; Guowei Shi
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388

Review 10.  Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance.

Authors:  Maddison Archer; Navneet Dogra; Natasha Kyprianou
Journal:  Cancers (Basel)       Date:  2020-10-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.